Uflex Ltd Q4 FY2026 Concall Summary

Key Takeaways

• Strong Q4 finish, but spreads already fading: EBITDA margin hit a 14-quarter high of 15.3%, driven by a temporary surge in spreads as market prices rose faster than raw material costs in March. Management confirmed spreads have since "moderated to a great extent," making the Q4 margin peak unsustainable.
• Packaging Films recovery is real, but uneven: The segment saw a meaningful sequential rebound, led by the Americas (up 23% QoQ) and Europe (up 12.9% QoQ), while India lagged as FMCG customers deferred purchases. The full-year decline of 1% underscores that a durable demand recovery is not yet broad-based.
• The capex cycle is pivoting to higher-margin solutions: Three value-accretive projects (Egypt aseptic, Mexico WPP, and the rPET recycling facility) are either just commissioned or near commissioning, and all carry margins above the UFlex average. The shift in EBITDA mix from films toward Packaging Solutions is the core structural story.
• Management declined to quantify the year ahead: Asked for a specific EBITDA margin range for FY27, the CFO called it "premature," citing the need to assess the post-Q4 spread normalization first. Leverage, interest cost, and capex guidance were all given in directional terms only.
• What to watch next quarter: The pace of spread normalization in Q1, the ramp-up trajectory of the three newly commissioned facilities, and any firming of India FMCG demand after the Q4 deferral cycle.

The Q4 Spread Phenomenon and What Comes Next

• What happened in March: Raw material prices (PET chips for BOPET, homopolymer for BOPP) rose dramatically, but market prices increased even more, so spreads improved significantly despite the raw material spike. This drove the 15.3% EBITDA margin, the highest in 14 quarters.
• What has already changed: Raw material prices have since softened and prevailing market prices have brought spreads down significantly. For BOPET particularly, spreads are significantly down compared to Q4.
• The margin sustainability question: The 70 bps improvement in full-year EBITDA margin to 12.8% is considered more sustainable than the Q4 margin expansion. Packaging films margins may not remain at current levels once they moderate to reflect larger industry trends, particularly in India.
• The Q1 reset: Management declined to give FY27 EBITDA guidance precisely because it needs to assess the extent of spread moderation in Q1 before forming a view. The Q4 exit rate is not the base to annualize.

Sumeet Kumar: "In Q4, the spreads generally improved significantly despite the rise in raw material prices, which not only could be passed through, but also, we could realize additional spreads. Having said that, I think post that... largely, I think this has moderated to a great extent."

Packaging Films: Regional Recovery, India Lag

• Americas led the rebound: 23% sequential and 18% YoY growth, supported by post-U.S. government shutdown normalization (the longest ever), improving CPG food demand, and seasonal post-holiday inventory replenishment.
• Europe rebounded sequentially but remains soft YoY: 12.9% QoQ growth, but demand stayed subdued on a YoY basis due to subdued consumer spending, fragile CPG demand, persistent energy and food inflation, and pressure from cheaper imports.
• India recovery was tentative: Sequential recovery came from demand normalization and strategic inventory replenishment, but the YoY decline was driven by softer FMCG demand. Volume growth moderated to 0.9% in Q4 FY26 as higher raw material costs and supply disruptions led customers to defer purchases amid expectations of price correction and lower inventory losses.
• MEA benefited from supply chain disruption: Volumes increased, driven primarily by Egypt and Dubai, with Egypt benefiting from localized sourcing opportunities arising from regional supply chain disruptions.
• Utilization improved broadly: Capacity utilization across most plants increased significantly on a sequential basis, reflected in stronger production and sales volumes.

The Capex Cycle: From Heavy Investment to Harvesting

• The pivot in capital allocation: Recent capex has been directed exclusively at value-accretive, higher-margin projects: aseptic packaging (debottlenecking India from Rs.700 cr to Rs.1,200 cr and the Egypt facility), WPP high-margin packaging bags, and the recycling facility. The era of large-scale commodity film capacity additions is effectively over.
• Three near-commission projects are the near-term EBITDA drivers: The 36,000 MT rPET and 3,600 MT rMLP recycling facility was commissioned end of April and will ramp up over the next 3 quarters. The Egypt aseptic facility (Rs.1,200 cr) and Mexico WPP facility are both expected to commission during H1 of the current year. Management expects substantial EBITDA to kick in from all three starting this year.
• The BOPP line is the one remaining large film project: A 54,000 MTPA BOPP line in Dharwad, India, is expected to be commissioned during FY27-28, with a significant part of the Rs.700-odd crore capex to be incurred during FY26-27.
• Management remains open to more capex: The CFO explicitly stated the company is "not saying no to the capex, which makes sense, which has higher margin and which is having the right product mix optimization," and did not confirm the capex cycle is over or that peak debt has been reached.
• CWIP to be capitalized: Per an analyst's math, Rs.1,900-2,000 crore of CWIP will be capitalized this year, which will flow into depreciation. Management expects improved EBITDA from new projects to absorb the additional interest and depreciation costs.

Sumeet Kumar: "We are not saying no to the capex, which makes sense, which has higher margin and which is having the right product mix optimization. There is always an opportunity to remain open to that capex, and that's what we will look at."

Packaging Solutions: The Margin Mix Shift

• The structural story: Packaging Solutions (flexible packaging, aseptic liquid packaging, holography, WPP, recycling) currently contributes approximately 40% of EBITDA versus approximately 60% from packaging films. That contribution is expected to increase as new capacities kick in, since all the recently commissioned and near-commission projects sit in the Packaging Solutions space.
• Aseptic packaging ramp-up: FY26 volume was 797 crore packs against capacity of 1,200 crore (for part of the year) and 700 crore for the whole year, representing approximately 80%+ utilization. The FY27 target is approximately 1,050 crore packs, including a part contribution from the Egypt facility during the year. The Egypt facility will be commissioned during H1, so only a 2-quarter impact is expected, with ramp-up during that period.
• WPP margin premium: The Mexico WPP facility has received very encouraging market response, largely for the U.S. market. Management is enthused by the ramp-up and expects margins to be much higher than the average UFlex margin, though it declined to specify a number.
• Recycling facility adds a new margin layer: The 36,000 MT rPET and 3,600 MT rMLP facility, commissioned end of April, is expected to add revenues with significant margin in the current year as it ramps up over the next 3 quarters.

Sumeet Kumar: "I'm limited in my response about a specific margin about the WPP, but I can tell you that this will be a much higher margin compared to the average margins at UFlex level."

Balance Sheet and Leverage

• Leverage improved but remains elevated: The ratio improved from 4.51 to 4.35 QoQ, still excluding the EBITDA contribution from near-commission projects. Management expects further improvement as EBITDA from those projects kicks in, making leverage a key monitorable.
• Interest cost stable for now: Consolidated interest cost of Rs.777 crore (approximately 5% of total revenues) is expected to largely remain in the same range. The average cost of funds has come down from above 9% to about 9% overall.
• International funding advantage: As the share of international business increases, the cost of funding for overseas business is much better than in India, which is expected to have a positive impact on the overall cost of funds. Refinancing options remain open but are premature to discuss.
• Depreciation will rise: Depreciation of approximately Rs.787 crore is expected, with recently commissioned project depreciation now reflecting. Management expects improved EBITDA from new projects to take care of the additional interest and depreciation costs.

Unanswered Questions and Pushback

• No EBITDA margin guidance: Management declined to give a specific EBITDA range for FY27, calling it "premature" and stating it needs to assess the impact of spread moderation in Q1 first.
• Peak debt not confirmed: When asked whether the company is "done with the peak debt" and the capex cycle, management did not directly answer, instead discussing openness to further value-accretive capex.
• Shareholder value creation left open: A suggestion about promoter creeping acquisition was not addressed; management said it would "take this as a takeaway" to be taken to promoters. On market valuation, the CFO acknowledged the perception of undervaluation but offered no specific unlock plan.
• Aseptic packaging segment mix undisclosed: Management declined to provide the portion of aseptic packaging sales going to the liquor segment, stating it does not dissect and disclose segment-level detail.
• Liquor packaging litigation risk deflected: On a PIL/litigation regarding liquor being sold in aseptic packaging (with some states requesting liquor only in glass), management said it is at a very early stage to comment, that it has been challenged, and that there is also a transition away from glass packaging: "we have to see how it plays out."

Sumeet Kumar: "I think it will be a little premature to give a sense of what kind of EBITDA range will be there for the year as a whole. I think we will have to probably assess that a little better before I can give you a sense of what the number or the range will be for the year as a whole."

Guidance & Commitments

Key Metrics